Lupin Atlantis Holdings

Lupin Atlantis Holdings is a strategic international subsidiary of Lupin Limited, headquartered in Zug, Switzerland. The company functions as a central hub for Lupin's global operations, managing intellectual property, international licensing, and business development activities. It plays a critical role in the commercialization of Lupin's specialty and generic portfolios, with a strong focus on respiratory, oncology, and biosimilar products. By leveraging its Swiss location, the entity facilitates global partnerships and streamlines the distribution of pharmaceutical products across diverse international markets. The company is instrumental in executing Lupin's growth strategy in complex generics and specialty medicines.